| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Institut für Pharmakologie und Toxikologie; 2 Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Universität Münster, D-48149 Münster; and 3 Institut für Pharmakologie, Universitäts-Krankenhaus Eppendorf, D-2024 Hamburg, Germany
The mechanism(s) underlying contractile dysfunction in cardiac stunning is not completely understood. The expression and/or the phosphorylation state of cardiac Ca2+ homoeostasis-regulating proteins might be altered in stunning. We tested this hypothesis in a well-characterized model of stunning. Conscious dogs were chronically instrumented, and the left anterior descending artery (LAD) was occluded for 10 min. Thereafter, reperfusion of the LAD was initiated. Tissues from reperfused LAD (stunned) and Ramus circumflexus (control) areas were obtained when left ventricular regional wall thickening fraction had recovered by 50%. Northern and Western blotting revealed no differences in the expression of the following genes: phospholamban, calsequestrin, sarco(endo)plasmic reticulum Ca2+-ATPase 2a, and the inhibitory subunit of troponin I (TnI). However, the phosphorylation state of TnI and phospholamban were reduced in the LAD area. Fittingly, cAMP levels were reduced by 28% (P < 0.05). It is concluded that the contractile dysfunction in cardiac stunning might be mediated in part by decreased levels of cAMP and subsequently a reduced phosphorylation state of phospholamban and TnI.
myocardial stunning; regulatory proteins; second messengers; phosphorylation
This article has been cited by other articles:
|
|
 |
|
  B. S. Palmer, P. F. Klawitter, P. J. Reiser, and M. G. Angelos Degradation of rat cardiac troponin I during ischemia independent of reperfusion Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1269 - H1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. R Eberli Stunned myocardium--an unfinished puzzle Cardiovasc Res, August 1, 2004; 63(2): 189 - 191. [Full Text] [PDF]
|
|
|
|
|
|
D. G. Soergel, D. Georgakopoulos, L. B. Stull, D. A. Kass, and A. M. Murphy Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1785 - H1792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Weber, M. A. G.{b.}e Hartlage, N. Rolf, M. Booke, E. Berendes, H. Van Aken, and A. Meissner Short-Term Administration of Ethanol Does Not Affect Functional Recovery from Myocardial Stunning in Awake Dogs Anesth. Analg., March 1, 2003; 96(3): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Lasley, M. S. Jahania, and R. M. Mentzer Jr. Beneficial effects of adenosine A2a agonist CGS-21680 in infarcted and stunned porcine myocardium Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1660 - H1666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Kim, R. K. Kudej, A. Yatani, Y.-K. Kim, G. Takagi, R. Honda, D. A. Colantonio, J. E. Van Eyk, D. E. Vatner, R. L. Rasmusson, et al. A Novel Mechanism for Myocardial Stunning Involving Impaired Ca2+ Handling Circ. Res., October 26, 2001; 89(9): 831 - 837. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
